Cargando…

Prediction of neoadjuvant chemotherapy response in breast cancer

Detalles Bibliográficos
Autor principal:	Myllys, Maiju
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Leibniz Research Centre for Working Environment and Human Factors 2021
Materias:	Letter to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8056062/ https://www.ncbi.nlm.nih.gov/pubmed/33883987 http://dx.doi.org/10.17179/excli2021-3607

Ejemplares similares

Immune responses during neoadjuvant chemotherapy in triple negative breast cancer
por: Ghallab, Ahmed
Publicado: (2020)

Highlight report: Relevance of T-cells, B-cells and immune checkpoint factors for prognosis of breast cancer
por: Myllys, Maiju
Publicado: (2019)

Predictive power of tertiary lymphoid structure signature for neoadjuvant chemotherapy response and immunotherapy benefit in HER2‐negative breast cancer
por: Bertucci, François, et al.
Publicado: (2023)

Comment on ‘Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques'
por: Kuerer, Henry M, et al.
Publicado: (2016)

Reply to Comment on ‘Diagnosis of pathological complete response to neoadjuvant chemotherapy in breast cancer by minimal invasive biopsy techniques'
por: Heil, Joerg
Publicado: (2016)

Bevacizumab Added to Neoadjuvant Chemotherapy in HER2-Negative Non-Metastatic Breast Cancer
por: Wan, Guoxing, et al.
Publicado: (2019)

Neoadjuvant chemotherapy in pancreatic cancer: innovative, but still difficult
por: Boeck, S, et al.
Publicado: (2014)

Neoadjuvant chemotherapy in technically unresectable adenocarcinoma of parotid
por: Dhumal, Sachin, et al.
Publicado: (2019)

Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy'
por: Altundag, Kadri
Publicado: (2017)

Neoadjuvant chemotherapy alters peripheral and tumour‐infiltrating immune cells in breast cancer revealed by single‐cell RNA sequencing
por: Zhou, Hanlin, et al.
Publicado: (2021)

Reply to ‘Comment on ‘Nomogram to predict pathologic complete response in HER2-positive breast cancer treated with neoadjuvant systemic therapy''
por: Fujii, Takeo, et al.
Publicado: (2017)

In Reply: Overall Survival of Resectable Metastatic Colon Cancer Treated With Neoadjuvant Chemotherapy or Adjuvant Chemotherapy in Non-academic Program
por: Hao, Zhonglin, et al.
Publicado: (2023)

Metabolic Syndrome Predicts Response to Neoadjuvant Chemotherapy in Breast Cancer
por: Lu, Ying, et al.
Publicado: (2022)

Neoadjuvant immune checkpoint inhibitor plus chemotherapy in rare tracheal tumors
por: Jiang, Ben‐Yuan, et al.
Publicado: (2021)

Breast cancer response to neoadjuvant chemotherapy: predictive markers and relation with outcome
por: Faneyte, I F, et al.
Publicado: (2003)

Tumor Sphericity Predicts Response in Neoadjuvant Chemotherapy for Invasive Breast Cancer
por: Li, Wen, et al.
Publicado: (2020)

The Role of Ultrasound Features in Predicting the Breast Cancer Response to Neoadjuvant Chemotherapy
por: El-Diasty, Mohamed T, et al.
Publicado: (2023)

Regarding “Neoadjuvant Versus Adjuvant Chemotherapy for Resectable Metastatic Colon Cancer in Non-academic and Academic Programs”
por: Su, I-Hsuan, et al.
Publicado: (2023)

Neoadjuvant chemotherapy in locally advanced invasive lobular carcinoma: A limited institutional experience
por: Gogia, Ajay, et al.
Publicado: (2018)

Neoadjuvant Therapy Should Be the Standard of Care for Every Node Positive Breast Cancer Patient
por: Hamdy, Omar
Publicado: (2018)

Identification of miRNA Signature in Breast Cancer to Predict Neoadjuvant Chemotherapy Response
por: Xing, Ai-Yan, et al.
Publicado: (2021)

Tumor-Associated Lymphocytes Predict Response to Neoadjuvant Chemotherapy in Breast Cancer Patients
por: Lee, Hee Jin, et al.
Publicado: (2013)

Histomorphological Factors Predicting the Response to Neoadjuvant Chemotherapy in Triple-Negative Breast Cancer
por: Jung, Yoon Yang, et al.
Publicado: (2016)

Prediction of neoadjuvant chemotherapy response using diffuse optical spectroscopy in breast cancer
por: Yu, Ying-hua, et al.
Publicado: (2017)

On-treatment biomarkers can improve prediction of response to neoadjuvant chemotherapy in breast cancer
por: Bownes, Richard J., et al.
Publicado: (2019)

Predicting the response to neoadjuvant chemotherapy for breast cancer: wavelet transforming radiomics in MRI
por: Zhou, Jiali, et al.
Publicado: (2020)

Contrast-enhanced ultrasonography for early prediction of response of neoadjuvant chemotherapy in breast cancer
por: Guo, Jiabao, et al.
Publicado: (2022)

Obstructive sleep apnea predicts pathologic response to neoadjuvant therapy in resected pancreatic ductal adenocarcinoma
por: Shoucair, Sami, et al.
Publicado: (2022)

Responses to docetaxel plus vinorelbine in metastatic breast cancer patients failing high-dose chemotherapy
por: Andres, R, et al.
Publicado: (2002)

Neoadjuvant radiotherapy in triple-negative breast cancer: “the past should not steal the present or hide the future”
por: To, Nhu Hanh, et al.
Publicado: (2022)

Study of internal mammary sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy
por: Cao, Xiao-Shan, et al.
Publicado: (2015)

Comment On: Prospective Phase II Trials Validate the Effect of Neoadjuvant Chemotherapy on Pattern of Recurrence in Pancreatic Adenocarcinoma
por: Liu, Zhi-Peng, et al.
Publicado: (2023)

Correspondence Regarding “Sleeve Lobectomy After Neoadjuvant Chemoimmunotherapy Versus Chemotherapy for Squamous Cell Lung Cancer: A Multicenter, Retrospective Study”
por: Takada, Kazuki, et al.
Publicado: (2023)

Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer
por: Joo, Sunghoon, et al.
Publicado: (2021)

A Narrative Review of Ultrasound Technologies for the Prediction of Neoadjuvant Chemotherapy Response in Breast Cancer
por: Wang, Jing, et al.
Publicado: (2021)

Prediction of axillary response after neoadjuvant chemotherapy in clinical node positive breast cancer
por: Zheng, Weizhen, et al.
Publicado: (2021)

Early prediction of response to neoadjuvant chemotherapy using contrast-enhanced ultrasound in breast cancer
por: Peng, Juan, et al.
Publicado: (2021)

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy
por: Manton, D J, et al.
Publicado: (2006)

Neoadjuvant chemotherapy in breast cancer: early response prediction with quantitative MR imaging and spectroscopy
por: Manton, D J, et al.
Publicado: (2006)

EARLY PREDICTION OF RESPONSE TO NEOADJUVANT CHEMOTHERAPY FOR LOCALLY ADVANCED BREAST CANCER USING MRI
por: KAWAMURA, MARIKO, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_b59udffu0bsf6f0nuhi3r6bf65